Figure 2.

(a–d): A 5-year-old girl presented with small focal peripheral RCH in the right eye and a large JRCH involving >270° of parapapillary area with SRF. Her BCVA was 20/30 in the right eye and CF CF in the left eye. There was complete regression of lesion in the right eye following one sitting of TTT, while multiple ICG-TTT sessions (a total of 7) were required for the left eye every 8–10 weeks interval along with intravitreal injection of dexamethasone. At the last follow-up, the BCVA remained stable with partial regression of lesion and persisting SRF. (e–h): An 11-year-old boy presented with a large JRCH in the left eye. At presentation, his BCVA was CF CF in the left eye. He underwent one sitting of ICG-TTT with intravitreal bevacizumab, following which there was increase tumor exudation and massive inferior exudative retinal detachment. Considering the size, location, and inferior exudative RD, he was referred for external beam radiation treatment (EBRT). At 2 months post treatment, BVCA remained stable with resolving exudative RD and partial tumor regression